Biochemical markers of alcoholism

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 8, 2007, Pages 953-961

  Hannuksela, Minna L ^a   Liisanantti, Marja K ^a   Nissinen, Antti E T ^a   Savolainen, Markku J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

glutamyltransferase; Acetaldehyde adducts; Alanine aminotransferase; Alcohol abuse; Alcoholism; Aspartate aminotransferase; Biomarkers; Carbohydrate deficient transferrin; Ethanol; Ethyl glucuronide; Fatty acid ethyl esters

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHOL; ACETALDEHYDE; ALANINE AMINOTRANSFERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ASPARTATE AMINOTRANSFERASE; BETA N ACETYLHEXOSAMINIDASE; BIOCHEMICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; CHOLESTEROL ESTER TRANSFER PROTEIN; CLUSTERIN; DOLICHOL; FATTY ACID ESTER; GAMMA GLUTAMYLTRANSFERASE; GLUCURONIC ACID; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLETHANOLAMINE; SIALIC ACID; TRANSFERRIN;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; ERYTHROCYTE; HUMAN; MEAN CORPUSCULAR VOLUME; MEDICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

ALCOHOL DRINKING; ALCOHOLISM; BIOLOGICAL MARKERS; HUMANS; MASS SCREENING;

EID: 34548744638     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.190     Document Type: Review

References (98)

1. Niemelä O. Biomarkers in alcoholism. Clin Chim Acta 2007;377:39-49.
2. Sillanaukee P. Laboratory markers of alcohol abuse. Alcohol Alcohol 1996;31:613-6.
3. Borucki K, Schreiner R, Dierkes J, Jachau K, Krause D, Westphal S, et al. Detection of recent ethanol intake with new markers: comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5-hydroxyindole acetic acid in urine. Alcohol Clin Exp Res 2005;29:781-7.
4. Taracha E, Habrat B, Wozniak P, Walkowiak J, Szukalski B. The activity of beta-hexosaminidase (uHex) and gamma-glutamyl-transferase (uGGT) in urine as noninvasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects. World J Biol Psychiatry 2001;2:184-9.
5. Roine RP, Turpeinen U, Ylikahri R, Salaspuro M. Urinary dolichol - a new marker of alcoholism. Alcohol Clin Exp Res 1987;11:525-7.
6. Sillanaukee P, Pönniö M, Jääskeläinen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest 1999;29:413-25.
7. Sillanaukee P, Pönniö M, Seppä K. Sialic acid: new potential marker of alcohol abuse. Alcohol Clin Exp Res 1999;23:1039-43.
8. Ghosh P, Hale EA, Lakshman MR. Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker. Alcohol 2001;25:173-9.
9. Kärkkäinen P, Salaspuro M. Beta-hexosaminidase in the detection of alcoholism and heavy drinking. Alcohol Alcohol Suppl 1991;1:459-64.
10. Wurst FM, Alexson S, Wolfersdorf M, Bechtel G, Forster S, Alling C, et al. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol 2004;39:33-8.
11. Helander A, Beck O. Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 2004;50:936-7.
12. Coccini T, Castoldi AF, Gandini C, Randine G, Vittadini G, Baiardi P, et al. Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. Alcohol Alcohol 2002;37:566-72.
13. Sillanaukee P, Strid N, Allen JP, Litten RZ. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin. Alcohol Clin Exp Res 2001;25:34-40.
14. Bortolotti F, De Paoli G, Tagliaro F. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J Chromatogr B Analyt Technol Biomed Life Sci 2006;841:96-109.
15. Musshoff F. Chromatographic methods for the determination of markers of chronic and acute alcohol consumption. J Chromatogr B Analyt Technol Biomed Life Sci 2002;781:457-80.
16. Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res 2004;28:1347-55.
17. Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 1999;19:261-71.
18. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 2002;26:332-9.
19. Sillanaukee P, Massot N, Jousilahti P, Vartiainen E, Poikolainen K, Olsson U, et al. Enhanced clinical utility of gamma-CDT in a general population. Alcohol Clin Exp Res 2000;24:1202-6.
20. Sillanaukee P, van der Gaag MS, Sierksma A, Hendriks HF, Strid N, Pönniö M, et al. Effect of type of alcoholic beverages on carbohydrate-deficient transferrin, sialic acid, and liver enzymes. Alcohol Clin Exp Res 2003;27:57-60.
21. Sadler DW, Girela E, Pounder DJ. Post mortem markers of chronic alcoholism. Forensic Sci Int 1996;82:153-63.
22. Malcolm R, Anton RF, Conrad SE, Sutherland S. Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol 1999;17:7-11.
23. Berkowicz A, Wallerstedt S, Wall K, Denison H. Analysis of carbohydrate-deficient transferrin (CDT) in vitreous humour as a forensic tool for detection of alcohol misuse. Forensic Sci Int 2003;137:119-24.
24. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
25. Thomas L. Gamma glutamyltransferase (GGT). In: Thomas L, editor. Clinical laboratory diagnostics. Frankfurt am Main: TH-Books, 1998:80-6.
26. Anton RF, Stout RL, Roberts JS, Allen JP. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics. Alcohol Clin Exp Res 1998;22:1456-62.
27. Hietala J, Puukka K, Koivisto H, Anttila P, Niemelä O. Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on GT reference intervals at population level. Alcohol Alcohol 2005;40:511-4.
28. Puukka K, Hietala J, Koivisto H, Anttila P, Bloigu R, Niemelä O. Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity. Am J Clin Nutr 2006;83:1351-4.
29. Nakanishi N, Nakamura K, Nakajima K, Suzuki K, Tatara K. Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men. Eur J Epidemiol 2000;16:419-23.
30. Sillanaukee P, Alho H, Strd N, Jousilahti P, Vartiainen E, Olsson U, et al. Effect of hormone balance on carbohydrate-deficient transferrin and glutamyltransferase in female social drinkers. Alcohol Clin Exp Res 2000;24:1505-9.
31. Sillanaukee P, Olsson U. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma- glutamyltransferase. Clin Chem 2001;47:681-5.
32. Hietala J, Koivisto H, Anttila P, Niemelä O. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006;41:528-33.
33. Anttila P, Järvi K, Latvala J, Blake JE, Niemelä O. A new modified gamma-%CDT method improves the detection of problem drinking: studies in alcoholics with or without liver disease. Clin Chim Acta 2003;338:45-51.
34. Chen J, Conigrave KM, Macaskill P, Whitfield JB, Irwig L. Combining carbohydrate-deficient transferrin and gamma-glutamyltransferase to increase diagnostic accuracy for problem drinking. Alcohol Alcohol 2003;38:574-82.
35. Koivisto H, Hietala J, Anttila P, Parkkila S, Niemelä O. Long-term ethanol consumption and macrocytosis: diagnostic and pathogenic implications. J Lab Clin Med 2006;147:191-6.
36. Thomas L. Alanine aminotransferase (ALT), aspartate aminotransferase (AST). In: Thomas L, editor. Clinical laboratory diagnostics. Frankfurt am Main: TH-Books, 1998:55-65.
37. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Can Med Assoc J 2005;172:367-79.
38. Ruhl CE, Everhart JE. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005;3:1260-8.
39. Hannuksela ML, Rämet ME, Nissinen AE, Liisanantti MK, Savolainen MJ. Effects of ethanol on lipids and atherosclerosis. Pathophysiology 2004;10:93-103.
40. Hannuksela M, Marcel YL, Kesäniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992;33:737-44.
41. Savolainen MJ, Hannuksela M, Seppänen S, Kervinen K, Kesäniemi YA. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest 1990;20:593-9.
42. Liinamaa MJ, Hannuksela ML, Kesäniemi YA, Savolainen MJ. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol 1997;17:2940-7.
43. Hannuksela ML, Savolainen MJ. Regulation of the quantity and quality of high-density lipoproteins by alcohol. In: Agarwal DP, Seitz HK, editors. Alcohol in health and disease. New York: Marcel Dekker Inc., 2001:573-95.
44. Hannuksela M, Kesäniemi YA, Savolainen MJ. Evaluation of plasma cholesteryl ester transfer protein (CETP) activity as a marker of alcoholism. Alcohol Alcohol 1992;27:557-62.
45. Hannuksela ML, Liisanantti MK, Savolainen MJ. Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis. Crit Rev Clin Lab Sci 2002;39:225-83.
46. Perova NV, Oganov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, et al. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men. Ann Epidemiol 1995;5:179-85.
47. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br Med J 1999;319:1523-8.
48. Schellenberg F, Beauge F, Bourdin C, Bourre JM, Weill J. Alcohol intoxication and sialic acid in erythrocyte membrane and in serum transferrin. Pharmacol Biochem Behav 1991;39:443-7.
49. Lindberg G, Ra° stam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993;103:123-9.
50. Kurtul N, Cil MY, Bakan E. The effects of alcohol and smoking on serum, saliva, and urine sialic acid levels. Saudi Med J 2004;25:1839-44.
51. Millar JS. The sialylation of plasma lipoproteins. Atherosclerosis 2001;154:1-13.
52. Calero M, Tokuda T, Rostagno A, Kumar A, Zlokovic B, Frangione B, et al. Functional and structural properties of lipid-associated apolipoprotein J (clusterin). Biochem J 1999;344:375-83.
53. Ghosh P, Hale EA, Lakshman R. Long-term ethanol exposure alters the sialylation index of plasma apolipoprotein J (Apo J) in rats. Alcohol Clin Exp Res 1999;23:720-5.
54. Humaloja K, Salaspuro M, Roine RP. Biliary excretion of dolichols and beta-hexosaminidase - effect of ethanol and glucagon. Lipids 1997;32:1169-72.
55. Stowell L, Stowell A, Garrett N, Robinson G. Comparison of serum beta-hexosaminidase isoenzyme B activity with serum carbohydrate-deficient transferrin and other markers of alcohol abuse. Alcohol Alcohol 1997;32:703-14.
56. Hultberg B, Isaksson A, Berglund M, Alling C. Increases and time-course variations in beta-hexosaminidase isoenzyme B and carbohydrate-deficient transferrin in serum from alcoholics are similar. Alcohol Clin Exp Res 1995;19:452-6.
57. Roine RP, Ylikahri R, Koskinen P, Suokas A, Hämäläinen J, Salaspuro M. Effect of heavy weekend drinking on urinary dolichol levels. Alcohol 1987;4:509-11.
58. Roine RP. Effects of moderate drinking and alcohol abstinence on urinary dolichol levels. Alcohol 1988;5:229-31.
59. Roine R, Nykänen I, Salaspuro M. Effect of alcohol on urinary and blood dolichols. Biochem Cell Biol 1992;70:404-7.
60. Stetter F, Gaertner HJ, Wiatr G, Mann K, Breyer-Pfaff U. Urinary dolichol - a doubtful marker of alcoholism. Alcohol Clin Exp Res 1991;15:938-41.
61. Giller E Jr, Nocks J, Hall H, Stewart C, Schnitt J, Sherman B. Platelet and fibroblast monoamine oxidase in alcoholism. Psychiatry Res 1984;12:339-47.
62. Castagnoli K, Murugesan T. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? Neurotoxicology 2004;25:279-91.
63. Berggren U, Fahlke C, Balldin J. Transient increase in platelet monoamine oxidase b activity during early abstinence in alcoholics: implications for research. Alcohol Alcohol 2000;35:377-80.
64. Esel E, Kose K, Turan MT, Basturk M, Sofuoglu S, Aslan SS, et al. Monoamine oxidase-B activity in alcohol withdrawal of smokers: is there any relationship with aggressiveness? Alcohol Alcohol 2002;37:272-6.
65. Beck O, Helander A. 5-Hydroxytryptophol as amarker for recent alcohol intake. Addiction 2003;98(Suppl 2):63-72.
66. Criteria Committee, National Council on Alcoholism. Criteria for the diagnosis of alcoholism. Ann Intern Med 1972;77:249-58.
67. Savola O, Niemelä O, Hillbom M. Blood alcohol is the best indicator of hazardous alcohol drinking in young adults and working-age patients with trauma. Alcohol Alcohol 2004;39:340-5.
68. Yu MC, Tang BK, Ross RK. A urinary marker of alcohol intake. Cancer Epidemiol Biomarkers Prev 1995;4:849-55.
69. Niemelä O. Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radic Biol Med 2001;31:1533-8.
70. Patel VB, Worrall S, Emery PW, Preedy VR. Protein adduct species in muscle and liver of rats following acute ethanol administration. Alcohol Alcohol 2005;40:485-93.
71. Hietala J, Koivisto H, Latvala J, Anttila P, Niemelä O. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers. Alcohol Clin Exp Res 2006;30:1693-8.
72. Korri UM, Nuutinen H, Salaspuro M. Increased blood acetate: a new laboratory marker of alcoholism and heavy drinking. Alcohol Clin Exp Res 1985;9:468-71.
73. Varga A, Hansson P, Johnson G, Alling C. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 2000;299:141-50.
74. Gunnarsson T, Karlsson A, Hansson P, Johnson G, Alling C, Odham G. Determination of phosphatidylethanol in blood from alcoholic males using high-performance liquid chromatography and evaporative light scattering or electrospray mass spectrometric detection. J Chromatogr B Biomed Sci Appl 1998;705:243-9.
75. Lundqvist C, Alling C, Aradottir S, Gustavsson L. Agonist-stimulated and basal phosphatidylethanol formation in neutrophils from alcoholics. Alcohol Clin Exp Res 1994;18:580-6.
76. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C. Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 1997;21:108-10.
77. Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C. Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 2006;41:431-7.
78. Diczfalusy MA, Bjorkhem I, Einarsson C, Hillebrant CG, Alexson SE. Characterization of enzymes involved in formation of ethyl esters of long-chain fatty acids in humans. J Lipid Res 2001;42:1025-32.
79. Pragst F, Auwaerter V, Sporkert F, Spiegel K. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci Int 2001;121:76-88.
80. Hasaba A, Laposata M. The synthesis and secretion of fatty acid ethyl esters from HepG2 cells are stimulated by lipoproteins and albumin. Alcohol Clin Exp Res 2001;25:338-43.
81. Bird DA, Laposata M, Hamilton JA. Binding of ethyl oleate to low density lipoprotein, phospholipid vesicles, and albumin: a 13C NMR study. J Lipid Res 1996;37:1449-58.
82. Auwarter V, Sporkert F, Hartwig S, Pragst F, Vater H, Diefenbacher A. Fatty acid ethyl esters in hair as markers of alcohol consumption. Segmental hair analysis of alcoholics, social drinkers, and teetotalers. Clin Chem 2001;47:2114-23.
83. Yegles M, Labarthe A, Auwarter V, Hartwig S, Vater H, Wennig R, et al. Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotallers. Forensic Sci Int 2004;145:167-73.
84. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000;45:23-41.
85. Ostrea EM Jr, Hernandez JD, Bielawski DM, Kan JM, Leonardo GM, Abela MB, et al. Fatty acid ethyl esters in meconium: are they biomarkers of fetal alcohol exposure and effect? Alcohol Clin Exp Res 2006;30:1152-9.
86. Chan D, Caprara D, Blanchette P, Klein J, Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem 2004;37:429-38.
87. Bearer CF, Santiago LM, O'Riordan MA, Buck K, Lee SC, Singer LT. Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr 2005;146:824-30.
88. Caprara DL, Klein J, Koren G. Diagnosis of fetal alcohol spectrum disorder (FASD): fatty acid ethyl esters and neonatal hair analysis. Ann Ist Super Sanita 2006;42:39-45.
89. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 2006;370:17-49.
90. Schmitt G, Droenner P, Skopp G, Aderjan R. Ethyl glucuronide concentration in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci 1997;42:1099-102.
91. Wurst FM, Kempter C, Metzger J, Seidl S, Alt A. Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 2000;20:111-6.
92. Helander A, Wielders JP, Te SR, Bergström JP. Comparison of HPLC and capillary electrophoresis for confirmatory testing of the alcohol misuse marker carbohydrate-deficient transferrin. Clin Chem 2005;51:1528-31.
93. Politi L, Morini L, Leone F, Polettini A. Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption? Addiction 2006;101:1408-12.
94. Schloegl H, Rost T, Schmidt W, Wurst FM, Weinmann W. Distribution of ethyl glucuronide in rib bone marrow, other tissues and body liquids as proof of alcohol consumption before death. Forensic Sci Int 2006;156:213-8.
95. Bicker W, Lammerhofer M, Keller T, Schuhmacher R, Krska R, Lindner W. Validated method for the determination of the ethanol consumption markers ethyl glucuronide, ethyl phosphate, and ethyl sulfate in human urine by reversed-phase/weak anion exchange liquid chromatography-tandem mass spectrometry. Anal Chem 2006;78:5884-92.
96. Wurst FM, Dresen S, Allen JP, Wiesbeck G, Graf M, Weinmann W. Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 2006;101:204-11.
97. Harasymiw JW, Vinson DC, Bean P. The early detection of alcohol consumption (EDAC) score in the identification of Heavy and at-risk drinkers from routine blood tests. J Addict Dis 2000;19:43-59.
98. Korzec A, de Bruijn C, van Lambalgen M. The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use. J Clin Epidemiol 2005;58:1024-32.